Na+ channels as targets for neuroprotective drugs

Trends in Pharmacological Sciences - Tập 16 - Trang 309-316 - 1995
Charles P. Taylor1
1Department of Neurological and Neurodegenerative Diseases, Parke-Davis Pharmaceutical Research Division, Warner-Lambert, 2800 Plymouth Road, Ann Arbor, MI 48105, USA

Tài liệu tham khảo

Stuart, 1994, Nature, 367, 69, 10.1038/367069a0 Taylor, 1993, Trends Neurosci., 16, 455, 10.1016/0166-2236(93)90077-Y Catterall, 1992, Physiol. Rev., 72, S15, 10.1152/physrev.1992.72.suppl_4.S15 Schaller, 1995, J. Neurosci., 15, 3231, 10.1523/JNEUROSCI.15-05-03231.1995 Ragsdale, 1991, Mol. Pharmacol., 40, 756 Lysko, 1994, Stroke, 25, 2476, 10.1161/01.STR.25.12.2476 Pauwels, 1990, J. Pharmacol. Exp. Ther., 255, 1117 Willow, 1982, Mol. Pharmacol., 22, 627 Leach, 1986, Epilepsia, 27, 490, 10.1111/j.1528-1157.1986.tb03573.x Hays, 1991, Soc. Neurosci. Abstr., 17, 956 Benoit, 1991, Pflügers Arch., 419, 603, 10.1007/BF00370302 Xie, X., Lancaster, B., Peakman, T. and Garthwaite, J. Pflügers Arch. (in press) Cheung, 1991, Epilepsy Res., 13, 107 Okiyama, 1995, J. Neurochem., 64, 802, 10.1046/j.1471-4159.1995.64020802.x Leach, 1993, Stroke, 24, 1063, 10.1161/01.STR.24.7.1063 Schauf, 1987, Brain Res., 413, 185, 10.1016/0006-8993(87)90168-5 Hebert, 1994, Mol. Pharmacol., 45, 1055 Hays, 1994, J. Pharm. Sci., 83, 1425, 10.1002/jps.2600831013 McGivern, 1994, Br. J. Pharmacol., 112, 485P Patmore, 1991, Br. J. Pharmacol., 104, 175P Zhu, 1992, J. Pharmacol. Exp. Ther., 260, 110 Ragsdale, 1993, Mol. Pharmacol., 43, 949 Thomsen, 1993, Mol. Pharmacol., 43, 955 Rock, 1991, Epilepsy Res., 8, 197, 10.1016/0920-1211(91)90064-M Lysko, 1994, Neurosci. Lett., 171, 77, 10.1016/0304-3940(94)90609-2 Margolin, 1994, Soc. Neurosci. Abstr., 20, 718 Kuo, 1994, Neuron, 12, 819, 10.1016/0896-6273(94)90335-2 Kuo, 1994, Mol. Pharmacol., 46, 716 Catterall, 1987, Trends Pharmacol. Sci., 8, 57, 10.1016/0165-6147(87)90011-3 Rogawski, 1990, Pharmacol. Rev., 42, 223 Leschinger, 1993, Exp. Brain Res., 96, 230, 10.1007/BF00227103 Segal, 1994, J. Neurophysiol., 72, 1874, 10.1152/jn.1994.72.4.1874 Weber, 1994, Brain Res., 664, 167, 10.1016/0006-8993(94)91967-4 Lysko, 1994, Stroke, 25, 2476, 10.1161/01.STR.25.12.2476 Stys, 1992, J. Neurophysiol., 67, 236, 10.1152/jn.1992.67.1.236 Yamasaki, 1991, Neurosci. Lett., 121, 251, 10.1016/0304-3940(91)90697-R Tasker, 1992, J. Neurosci., 12, 4298, 10.1523/JNEUROSCI.12-11-04298.1992 Xie, 1994, Brain Res., 652, 216, 10.1016/0006-8993(94)90230-5 Prenen, 1988, Exp. Neurol., 99, 118, 10.1016/0014-4886(88)90132-X Rasool, 1990, Stroke, 21, 929, 10.1161/01.STR.21.6.929 Fern, 1993, J. Pharmacol. Exp. Ther., 266, 1549 Boxer, 1990, Stroke, 21, 47 Rataud, 1994, Neurosci. Lett., 172, 19, 10.1016/0304-3940(94)90652-1 Taft, 1989, Brain Res., 483, 143, 10.1016/0006-8993(89)90045-0 Hayakawa, 1994, Life Sci., 54, 387, 10.1016/0024-3205(94)00696-2 Smith, 1995, Stroke, 26, 117, 10.1161/01.STR.26.1.117 Wiard, 1995, Stroke, 26, 466, 10.1161/01.STR.26.3.466 Meldrum, 1992, Brain Res., 593, 1, 10.1016/0006-8993(92)91254-C Lekieffre, 1993, Neuroscience, 56, 93, 10.1016/0306-4522(93)90565-W Smith, 1993, NeuroReport, 4, 1339, 10.1097/00001756-199309150-00013 Hayakawa, 1994, Em. J. Pharmacol., 257, 131, 10.1016/0014-2999(94)90704-8 Rothstein, J. D. and Kund, R. W. J. Neurochem. (in press) Pratt, 1992, Neurosci. Lett., 140, 225, 10.1016/0304-3940(92)90108-J Wahl, 1993, Eur. J. Pharmacol., 230, 209, 10.1016/0014-2999(93)90804-Q Kucharczyk, 1991, Radiology, 179, 221, 10.1148/radiology.179.1.2006281 Wauquier, 1989, Neuropharmacology, 28, 837, 10.1016/0028-3908(89)90176-7 Silverstein, 1986, Stroke, 17, 477, 10.1161/01.STR.17.3.477 Okiyama, 1995, J. Neurochem., 64, 802, 10.1046/j.1471-4159.1995.64020802.x Sun, 1995, Brain Res., 637, 133, 10.1016/0006-8993(94)01413-C Stys, 1992, J. Neurosci., 12, 430, 10.1523/JNEUROSCI.12-02-00430.1992 Squire, I. B., Lees, K. R., Pryse-Phillips, W., Kertesz, A. and Bamford, J. in Proceedings of the Second International Conference on Neuroprotective Agents: Clinical and Experimental Aspects, NY Academy of Sciences (in press) Bensimon, 1994, New Engl. J. Med., 330, 585, 10.1056/NEJM199403033300901 Rothstein, 1993, 90, 6591 Kass, 1992, Neuroscience, 49, 537, 10.1016/0306-4522(92)90224-P Hansen, 1985, Physiol. Rev., 65, 101, 10.1152/physrev.1985.65.1.101 Kiedrowski, 1994, Mol. Pharmacol., 45, 1050 Koch, 1994, J. Neurosci., 14, 2585, 10.1523/JNEUROSCI.14-05-02585.1994 Borin, 1994, Am. J. Physiol., 266, C311, 10.1152/ajpcell.1994.266.1.C311 Nedergaard, 1986, J. Cereb. Blood Flow Metab., 6, 607, 10.1038/jcbfm.1986.108 Gill, 1992, J. Cereb. Blood Flow Metab., 12, 371, 10.1038/jcbfm.1992.54 Iijima, 1992, J. Cereb. Blood Flow Metab., 12, 727, 10.1038/jcbfm.1992.103 Millan, M. H., Chapman, A. G. and Meldrum, B. S. Br. J. Pharmacol. (in press) Szatkowski, 1994, Trends Neurosci., 17, 359, 10.1016/0166-2236(94)90040-X Taylor, 1995, J. Neurosci. Methods, 59, 121, 10.1016/0165-0270(94)00202-R